VAMP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.284200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.481000E-01
Normal-vs-Stage2
4.823400E-01
Normal-vs-Stage3
7.666400E-01
Normal-vs-Stage4
1.569230E-01
Stage1-vs-Stage2
6.130200E-01
Stage1-vs-Stage3
5.042200E-01
Stage1-vs-Stage4
7.907800E-02
Stage2-vs-Stage3
2.292600E-01
Stage2-vs-Stage4
2.020400E-01
Stage3-vs-Stage4
8.501800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.314600E-01
Normal-vs-AfricanAmerican
6.440200E-01
Normal-vs-Asian
6.735800E-01
Caucasian-vs-AfricanAmerican
8.212200E-01
Caucasian-vs-Asian
9.837800E-01
AfricanAmerican-vs-Asian
8.758800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.702200E-01
Normal-vs-Female
4.884600E-01
Male-vs-Female
4.087400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.452000E-01
Normal-vs-Age(41-60Yrs)
2.471600E-01
Normal-vs-Age(61-80Yrs)
6.841600E-01
Normal-vs-Age(81-100Yrs)
7.818600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.812430E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.569400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.120800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.019400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.654200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.345800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.415600E-01
Normal-vs-Daily Drinker
4.705000E-01
Normal-vs-Weekly Drinker
5.465400E-01
Normal-vs-Occasional Drinker
2.113000E-01
Normal-vs-Social Drinker
7.591600E-01
Non Drinker-vs-Daily Drinker
2.334800E-01
Non Drinker-vs-Weekly Drinker
4.693600E-01
Non Drinker-vs-Occasional Drinker
1.758330E-02
Non Drinker-vs-Social Drinker
7.312800E-01
Daily Drinker-vs-Weekly Drinker
7.056200E-01
Daily Drinker-vs-Occasional Drinker
1.458040E-01
Daily Drinker-vs-Social Drinker
4.254400E-01
Weekly Drinker-vs-Occasional Drinker
1.033640E-01
Weekly Drinker-vs-Social Drinker
6.716200E-01
Occasional Drinker-vs-Social Drinker
5.141900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.184800E-01
Normal-vs-Grade 2
1.108590E-01
Normal-vs-Grade 3
5.985600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.838500E-04
Grade 1-vs-Grade 3
2.000500E-03
Grade 1-vs-Grade 4
8.184800E-01
Grade 2-vs-Grade 3
4.797000E-01
Grade 2-vs-Grade 4
1.108590E-01
Grade 3-vs-Grade 4
5.985600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.341400E-01
Normal-vs-NonDiabetic
5.497400E-01
Diabetic-vs-NonDiabetic
9.613800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.301800E-01
Normal-vs-NoPancreatitis
5.438600E-01
Pancreatitis-vs-NoPancreatitis
8.861000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.343400E-01
Normal-vs-N1
5.237400E-01
N0-vs-N1
6.486800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.920200E-01
Normal-vs-TP53-NonMutant
7.752600E-01
TP53-Mutant-vs-TP53-NonMutant
1.72864999999911E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
